Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Modification of T cell responses by stem cell mobilization requires direct signaling of the T cell by G-CSF and IL-10.

MacDonald KP, Le Texier L, Zhang P, Morris H, Kuns RD, Lineburg KE, Leveque L, Don AL, Markey KA, Vuckovic S, Bagger FO, Boyle GM, Blazar BR, Hill GR.

J Immunol. 2014 Apr 1;192(7):3180-9. doi: 10.4049/jimmunol.1302315. Epub 2014 Feb 28.

2.

Differences in the phenotype, cytokine gene expression profiles, and in vivo alloreactivity of T cells mobilized with plerixafor compared with G-CSF.

Lundqvist A, Smith AL, Takahashi Y, Wong S, Bahceci E, Cook L, Ramos C, Tawab A, McCoy JP Jr, Read EJ, Khuu HM, Bolan CD, Joo J, Geller N, Leitman SF, Calandra G, Dunbar C, Kurlander R, Childs RW.

J Immunol. 2013 Dec 15;191(12):6241-9. doi: 10.4049/jimmunol.1301148. Epub 2013 Nov 15.

3.

Significant mobilization of both conventional and regulatory T cells with AMD3100.

Kean LS, Sen S, Onabajo O, Singh K, Robertson J, Stempora L, Bonifacino AC, Metzger ME, Promislow DE, Mattapallil JJ, Donahue RE.

Blood. 2011 Dec 15;118(25):6580-90. doi: 10.1182/blood-2011-06-359331. Epub 2011 Oct 11.

4.

Impact of donor hematopoietic cells mobilized with G-CSF and plerixafor on murine acute graft-versus-host-disease.

Arbez J, Saas P, Lamarthée B, Malard F, Couturier M, Mohty M, Gaugler B.

Cytotherapy. 2015 Jul;17(7):948-55. doi: 10.1016/j.jcyt.2015.02.009. Epub 2015 Mar 23.

PMID:
25813681
5.

Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation.

MacDonald KP, Rowe V, Filippich C, Thomas R, Clouston AD, Welply JK, Hart DN, Ferrara JL, Hill GR.

Blood. 2003 Mar 1;101(5):2033-42. Epub 2002 Oct 17.

6.

Effective mobilization of hematopoietic progenitor cells in G-CSF mobilization defective CD26-/- mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis.

Paganessi LA, Walker AL, Tan LL, Holmes I, Rich E, Fung HC, Christopherson KW 2nd.

Exp Hematol. 2011 Mar;39(3):384-90. doi: 10.1016/j.exphem.2010.12.003. Epub 2010 Dec 17.

7.

Granulocyte colony-stimulating factor affects the distribution and clonality of TRGV and TRDV repertoire of T cells and graft-versus-host disease.

Xuan L, Wu X, Zhang Y, Fan Z, Ling Y, Huang F, Zhang F, Zhai X, Liu Q.

J Transl Med. 2011 Dec 15;9:215. doi: 10.1186/1479-5876-9-215.

8.

G-CSF-treated donor CD4+ T cells attenuate acute GVHD through a reduction in Th17 cell differentiation.

Joo YD, Lee WS, Won HJ, Lee SM, Kim HR, Park JK, Park SG, Choi IW, Choi I, Seo SK.

Cytokine. 2012 Oct;60(1):277-83. doi: 10.1016/j.cyto.2012.06.289. Epub 2012 Jul 21.

PMID:
22819244
11.

NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs.

Morris ES, MacDonald KP, Rowe V, Banovic T, Kuns RD, Don AL, Bofinger HM, Burman AC, Olver SD, Kienzle N, Porcelli SA, Pellicci DG, Godfrey DI, Smyth MJ, Hill GR.

J Clin Invest. 2005 Nov;115(11):3093-103. Epub 2005 Oct 13.

12.

Effect of granulocyte colony-stimulating factor mobilization on the expression patterns, clonality and signal transduction of TRAV and TRBV repertoire.

Xuan L, Wu X, Wu M, Zhang Y, Liu H, Fan Z, Sun J, Liu Q.

Immunobiology. 2012 Aug;217(8):816-22. doi: 10.1016/j.imbio.2012.05.004. Epub 2012 May 11.

PMID:
22658922
13.

Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial.

Nademanee AP, DiPersio JF, Maziarz RT, Stadtmauer EA, Micallef IN, Stiff PJ, Hsu FJ, Bridger G, Bolwell BJ.

Biol Blood Marrow Transplant. 2012 Oct;18(10):1564-72. doi: 10.1016/j.bbmt.2012.05.017. Epub 2012 Jun 6.

14.

AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates.

Larochelle A, Krouse A, Metzger M, Orlic D, Donahue RE, Fricker S, Bridger G, Dunbar CE, Hematti P.

Blood. 2006 May 1;107(9):3772-8. Epub 2006 Jan 26.

16.

Graft monocytic myeloid-derived suppressor cell content predicts the risk of acute graft-versus-host disease after allogeneic transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood stem cells.

Vendramin A, Gimondi S, Bermema A, Longoni P, Rizzitano S, Corradini P, Carniti C.

Biol Blood Marrow Transplant. 2014 Dec;20(12):2049-55. doi: 10.1016/j.bbmt.2014.09.011. Epub 2014 Sep 20.

17.

In vivo engineering of mobilized stem cell grafts with the immunomodulatory drug FTY720 for allogeneic transplantation.

Lakshmikanth T, Heuts F, Muvva SS, Wallin RP, Persson AK, Fauriat C, Applequist SE, Ljunggren HG, Höglund P, Kärre K, Svensson M, Juarez JG.

Eur J Immunol. 2016 Jul;46(7):1758-69. doi: 10.1002/eji.201545991. Epub 2016 May 17.

18.

Enhanced unique pattern of hematopoietic cell mobilization induced by the CXCR4 antagonist 4F-benzoyl-TN14003.

Abraham M, Biyder K, Begin M, Wald H, Weiss ID, Galun E, Nagler A, Peled A.

Stem Cells. 2007 Sep;25(9):2158-66. Epub 2007 May 24.

19.

[Influence of G-CSF mobilization on functions of donor T lymphocyte subpopulation and acute graft-versus-host disease].

Liu QG, Yang DL, Huang Y, Jiang EL, Zhou SY, He Y, Wang ZD, Wang M, Zhou Z, Zai WJ, Feng SZ, Han MZ.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Feb;14(1):107-11. Chinese.

PMID:
16584603
20.

In and out of the niche: perspectives in mobilization of hematopoietic stem cells.

Mohty M, Ho AD.

Exp Hematol. 2011 Jul;39(7):723-9. doi: 10.1016/j.exphem.2011.05.004. Epub 2011 May 13. Review.

PMID:
21624427

Supplemental Content

Support Center